相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity
Jian Guan et al.
EMBO MOLECULAR MEDICINE (2014)
Direct detection of ABCA1-dependent HDL formation based on lipidation-induced hydrophobicity change in apoA-I
Risa Omura et al.
JOURNAL OF LIPID RESEARCH (2014)
Dual Role of an N-terminal Amyloidogenic Mutation in Apolipoprotein A-I DESTABILIZATION OF HELIX BUNDLE AND ENHANCEMENT OF FIBRIL FORMATION
Emi Adachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland
Carol A. Traynor et al.
NEPHROLOGY (2013)
Heparan Sulfate Subdomains that are Degraded by Sulf Accumulate in Cerebral Amyloid β Plaques of Alzheimer's Disease Evidence from Mouse Models and Patients
Tomomi Hosono-Fukao et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Organ-specific Sulfation Patterns of Heparan Sulfate Generated by Extracellular Sulfatases Sulf1 and Sulf2 in Mice
Satoshi Nagamine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I
Dorota Rowczenio et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations
Monica Gomaraschi et al.
CLINICA CHIMICA ACTA (2011)
Lipoprotein Lipase Is a Novel Amyloid β (Aβ)-binding Protein That Promotes Glycosaminoglycan-dependent Cellular Uptake of Aβ in Astrocytes
Kazuchika Nishitsuji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Human Apolipoprotein A-I-Derived Amyloid: Its Association with Atherosclerosis
Nahuel A. Ramella et al.
PLOS ONE (2011)
Modulation of Aβ42 fibrillogenesis by glycosaminoglycan structure
Juan Jose Valle-Delgado et al.
FASEB JOURNAL (2010)
Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88
Md Motarab Hossain et al.
GLYCOBIOLOGY (2010)
Heparan sulfate mediates amyloid-beta internalization and cytotoxicity
Elina Sandwall et al.
GLYCOBIOLOGY (2010)
Kinetic Analysis of Amyloid Formation in the Presence of Heparan Sulfate FASTER UNFOLDING AND CHANGE OF PATHWAY
Neda Motamedi-Shad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Daniel J. Rader et al.
JOURNAL OF LIPID RESEARCH (2009)
Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I
Masafumi Tanaka et al.
BIOCHEMISTRY (2008)
Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins
A. R. Tall
JOURNAL OF INTERNAL MEDICINE (2008)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications
Robert Kisilevsky et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2007)
Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications (vol 14, pg 21, 2007)
Robert Kisilevsky et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2007)
Structure, function and amyloidogenic propensity of apolipoprotein A-1
Laura Obici et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2006)
Lysosomes and autophagy in cell death control
G Kroemer et al.
NATURE REVIEWS CANCER (2005)
Heparan sulfate is a cellular receptor for purified infectious prions
L Horonchik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heparan sulfate proteoglycans in glomerular inflammation
ALWMM Rops et al.
KIDNEY INTERNATIONAL (2004)
Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist noggin
BL Viviano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prion protein conversion in vitro
S Supattapone
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling
XB Ai et al.
JOURNAL OF CELL BIOLOGY (2003)
Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans
M Morimoto-Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Monitoring of caspase-8/FLICE processing and activation upon fas stimulation with novel antibodies directed against a cleavage site for caspase-8 and its substrate, FLICE-like inhibitory protein (FLIP)
Y Niikura et al.
JOURNAL OF BIOCHEMISTRY (2002)
The effects of altered apolipoprotein A-I structure on plasima HDL concentration
MG Sorci-Thomas et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Mitochondrial and nonmitochondrial reduction of MTT: Interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes
T Bernas et al.
CYTOMETRY (2002)
Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies
MABA Dennissen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro
JA Cohlberg et al.
BIOCHEMISTRY (2002)
Heparan sulfate: growth control with a restricted sequence menu
JT Gallagher
JOURNAL OF CLINICAL INVESTIGATION (2001)
Structural models of human apolipoprotein A-I: a critical analysis and review
CG Brouillette et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2001)
分享论文
